Insurance benefit of Baraclude extended to children over 2
A BMS Korea’s hepatitis B treatment, ‘Baraclude’ will be extended in the health insurance benefit to children over 2. Moreover, a Boehringer Ingelheim’s chronic obstructive pulmonary disease(COPD) treatment, ‘Vahelva Respimat’ will be applied for the health insurance.
Recently, the Ministry of ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.